Company page
Actinium Pharmaceuticals, Inc. (delaware)
Actinium Pharmaceuticals, Inc. is a Delaware-based public company traded under the ticker ATNM in the American market. The company has a market capitalization of approximately $32.3 million. Actinium focuses on developing targeted therapies for cancer treatment.
- Ticker
- ATNM:AMEX
- Asset type
- Stock
- Market cap
- $32.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- AMEX
- Currency
- USD